Iovance Biotherapeutics Inc (IOVA) Inventory Turnover Ratio, from first quarter 2026 to first quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Iovance Biotherapeutics inc   (NASDAQ: IOVA)
 

Iovance Biotherapeutics Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the first quarter 2026, Iovance Biotherapeutics Inc 's inventory turnover ratio sequentially decreased to 3.14 in the first quarter 2026, unsurprisingly, as the Iovance Biotherapeutics Inc markets continue to deteriorate, and IOVA's faces growing challenges to bring down its inventories. Iovance Biotherapeutics Inc 's average inventory processing period in the Mar 31 2026 quarter, has increased to 116 days, from 115 days, in the Dec 31 2025 quarter.

Within Healthcare sector 120 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 746 in the fourth quarter 2025, to 995.

IOVA Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Iovance Biotherapeutics Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

IOVA Inventory Turnover Ratio (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Inventory Growth -10.94 % 0.31 % 34.04 % 78.91 % 272.06 %
Y / Y Cost of Sales Growth -14.56 % -37.86 % -3.38 % 80.64 % 585.04 %
Inventory Turnover Ratio (TTM) 3.14 3.17 3.48 3.73 3.63
IOVA's Total Ranking # 995 # 746 # 506 # 614 # 756
Average inventory processing period 116 115 105 98 101
Seq. Inventory Growth 12.96 % -0.06 % 3.77 % -23.97 % 27.22 %
Seq. Cost of Sales Growth 50.16 % -26.44 % -32.1 % 13.92 % 9.22 %




Inventory Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 13
Healthcare Sector # 121
Overall Market # 995

Inventory Turnover Ratio Statistics
High Average Low
3.73 3.2 1.54
(Jun 30 2025)   (Mar 31 2024)



IOVA Company Profile >> Back to IOVA Efficiency Comparisons >> Compare IOVA Inventory Turnover Ratio to its Competitors

Financial Statements
Iovance Biotherapeutics Inc 's Inventories $ 58 Millions Visit IOVA's Balance sheet
Iovance Biotherapeutics Inc 's Cost of Revenues TTM $ 166 Millions Visit IOVA's Income Statement
What are IOVA's Sales? Visit IOVA's Sales by Segment

Other Inventory Turnover Ratios
Iovance Biotherapeutics Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Biotechnology & Pharmaceuticals Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
IOVA's Inventory Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for IOVA's Competitors
Inventory Turnover Ratio for IOVA's Suppliers
Inventory Turnover Ratio for IOVA's Customers

You may also want to know
IOVA's Sales Growth Rates IOVA's Pe Price to earnings ratio IOVA's Receivables Turnover Ratio IOVA's Stock Quote
IOVA's Net Income Growth Rates IOVA's Ps Price to Sales ratio IOVA's Sales per Employee IOVA's Asset Turnover Ratio
IOVA's Net Margin IOVA's Pb Price to Book ratio IOVA's Financial Strength Ratios IOVA's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Mar 31 2026 Inventories at quarter ending Mar 31 2026
Inogen Inc   7.80 $ 195.741  Millions$ 25  Millions
Cardiff Lexington Corporation  7.70 $ 4.159  Millions$ 1  Millions
Novavax inc   7.67 $ 89.620  Millions$ 12  Millions
Prophase Labs Inc   7.64 $ 2.361  Millions$ 0  Millions
Bellevue Life Sciences Acquisition Corp  7.62 $ 1.986  Millions$ 0  Millions
Lifemd Inc   7.60 $ 24.000  Millions$ 3  Millions
Tarsus Pharmaceuticals Inc   7.60 $ 31.627  Millions$ 4  Millions
Charles River Laboratories International inc   7.56 $ 2,346.239  Millions$ 310  Millions
Adaptive Biotechnologies Corporation  7.43 $ 73.088  Millions$ 10  Millions
Puma Biotechnology Inc   7.19 $ 58.025  Millions$ 8  Millions
Fonar Corporation  7.06 $ 19.685  Millions$ 3  Millions
Carlisle Companies Incorporated  6.71 $ 3,206.100  Millions$ 478  Millions
Hims and Hers Health Inc   6.58 $ 670.000  Millions$ 102  Millions
Vanda Pharmaceuticals Inc   6.54 $ 12.682  Millions$ 2  Millions
Twist Bioscience Corporation  6.50 $ 196.251  Millions$ 30  Millions
Phathom Pharmaceuticals Inc   6.48 $ 30.871  Millions$ 5  Millions
Precision Optics Corporation Inc   6.47 $ 24.932  Millions$ 4  Millions
Nuo Therapeutics Inc   6.42 $ 1.331  Millions$ 0  Millions
Collegium Pharmaceutical Inc   6.41 $ 256.071  Millions$ 40  Millions
Veracyte Inc   6.05 $ 132.000  Millions$ 22  Millions
Kewaunee Scientific Corporation  5.98 $ 200.155  Millions$ 33  Millions
Adm Tronics Unlimited Inc   5.93 $ 1.992  Millions$ 0  Millions
Align Technology inc   5.81 $ 1,327.000  Millions$ 228  Millions
Transmedics Group Inc   5.71 $ 260.151  Millions$ 46  Millions
Opko Health Inc   5.69 $ 372.048  Millions$ 65  Millions
Avantor Inc   5.55 $ 4,447.000  Millions$ 801  Millions
Steris Plc  5.27 $ 3,309.400  Millions$ 628  Millions
Bristol myers Squibb Company  5.24 $ 14,324.000  Millions$ 2,735  Millions
Harrow Inc   5.11 $ 69.568  Millions$ 14  Millions
Integer Holdings Corporation  5.11 $ 1,365.000  Millions$ 267  Millions

Date modified: 2026-08-29T17:25:14+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.